ArticleBMC cancer2026

Beyond tumor burden: PET/CT-derived psoas muscle quality and survival outcomes in metastatic NSCLC patients treated with nivolumab.

Burcu Gulbagci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.